Literature DB >> 2551846

Synthesis of radioiodinated N-succinimidyl iodobenzoate: optimization for use in antibody labelling.

P K Garg1, G E Archer, D D Bigner, M R Zalutsky.   

Abstract

N-succinimidyl-3-(tri-n-butylstannyl)benzoate (m-BuATE), N-succinimidyl-3-(tri-methylstannyl)benzoate (m-MeATE) and N-succinimidyl-4-(tri-n-butylstannyl)benzoate (p-BuATE) were synthesized and radioiodinated using either N-chlorosuccinimide (NCS) or t-butylhydroperoxide (TBHP) as the oxidant. Radiohalogenation of m-MeATE proceeded more rapidly than m-BuATE. NCS was the more efficient oxidant at reaction times less than 15 min; use of both TBHP and NCS resulted in nearly quantitative yields after 15 min when m-MeATE was used. Using NCS, achieving optimal antibody coupling and specific binding required purification of the active ester by HPLC; in contrast, with TBHP, only Sep-Pak purification was needed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551846     DOI: 10.1016/0883-2889(89)90131-7

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum A        ISSN: 0883-2889


  10 in total

1.  Shelf-life of ɛ-lysyl-3-(trimethylstannyl)benzamide immunoconjugates, precursors for 211At labeling of antibodies.

Authors:  Emma Aneheim; Jenny Halleröd; Per Albertsson; Holger Jensen; Stellan Holgersson; Sture Lindegren
Journal:  Cancer Biother Radiopharm       Date:  2015-01-14       Impact factor: 3.099

2.  Labeling Monoclonal Antibody with α-emitting 211At at High Activity Levels via a Tin Precursor.

Authors:  Ganesan Vaidyanathan; Oscar R Pozzi; Jaeyeon Choi; Xiao-Guang Zhao; Shawn Murphy; Michael R Zalutsky
Journal:  Cancer Biother Radiopharm       Date:  2020-02-28       Impact factor: 3.099

3.  Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity.

Authors:  M R Zalutsky; P K Garg; H S Friedman; D D Bigner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies.

Authors:  G Vaidyanathan; B J White; D J Affleck; X G Zhao; P C Welsh; D McDougald; J Choi; M R Zalutsky
Journal:  Bioorg Med Chem       Date:  2012-10-29       Impact factor: 3.641

5.  Reagents for astatination of biomolecules. 4. Comparison of maleimido-closo-decaborate(2-) and meta-[(211)At]astatobenzoate conjugates for labeling anti-CD45 antibodies with [(211)At]astatine.

Authors:  D Scott Wilbur; Monica S Thakar; Donald K Hamlin; Erlinda B Santos; Ming-Kuan Chyan; Hirohisa Nakamae; John M Pagel; Oliver W Press; Brenda M Sandmaier
Journal:  Bioconjug Chem       Date:  2009-09-04       Impact factor: 4.774

6.  Radiopharmaceutical chemistry of targeted radiotherapeutics, part 4: Strategies for 211At labeling at high activities and radiation doses of 211At α-particles.

Authors:  Oscar R Pozzi; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2016-12-10       Impact factor: 2.408

7.  N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: influence of isomeric substitution on radiolabeling and target cell residualization.

Authors:  Jaeyeon Choi; Ganesan Vaidyanathan; Eftychia Koumarianou; Darryl McDougald; Marek Pruszynski; Takuya Osada; Tony Lahoutte; H Kim Lyerly; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2014-08-01       Impact factor: 2.408

8.  Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibody.

Authors:  R H Larsen; O S Bruland; P Hoff; J Alstad; E K Rofstad
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

9.  Covalent core-radiolabeling of polymeric micelles with 125I/211At for theranostic radiotherapy.

Authors:  Emanuel Sporer; Christian B M Poulie; Tom Bäck; Sture Lindegren; Holger Jensen; Paul J Kempen; Andreas Kjaer; Matthias M Herth; Andreas I Jensen
Journal:  Nanotheranostics       Date:  2022-07-18

10.  In vitro selectivity, in vivo biodistribution and tumour uptake of annexin V radiolabelled with a positron emitting radioisotope.

Authors:  D R Collingridge; M Glaser; S Osman; H Barthel; O C Hutchinson; S K Luthra; F Brady; L Bouchier-Hayes; S J Martin; P Workman; P Price; E O Aboagye
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.